Sometimes do you feel a need to say something because an injustice calls out to you, demands your voice, all our voices, however much our calls may be lost in the din? Such was my feeling when reading about the world’s yawn in response to one of the world’s worst humanitarian crises, a famine that […]
Last week, we learned that the sugar industry paid Harvard scientists to minimize the link between sugar and heart disease, blaming saturated fat instead. Unfortunately, scientific evidence isn’t the only thing the industry has been influencing: a soda company in Colombia has successfully pushed for the suspension of a television advertisement warning the public about […]
This post was written by Katie Keith, Adjunct Professor at Georgetown Law. Any questions about this post should be directed to Katie.Keith@georgetown.edu. Controversy around the more than 400 percent increase in the price of EpiPens is just the latest in a year filled with stories of dramatic drug price gouging. Indeed, health headlines have been […]
Posted in Global Health;
This post was written by Andrew Hennessy-Strahs, a 2017 Global Health Law LL.M. Candidate at Georgetown University Law Center. Any questions or comments can be directed to firstname.lastname@example.org. September 14, 2016 marks the twenty-six year anniversary of the first successful human gene therapy in the world. Doctors in the National Institute of Health, in Bethesda […]
Signup for our mailing list and stay up to date on the latest happenings at The O’Neill Institute
Or sign up for our RSS Feed
The views reflected in this blog are those of the individual authors and do not necessarily represent those of the O’Neill Institute for National and Global Health Law or Georgetown University. This blog is solely informational in nature, and not intended as a substitute for competent legal advice from a licensed and retained attorney in your state or country.